I Led Harvard’s Medical School, and I Fear for What’s to Come
Dr. Jeffrey Flier is an endocrinologist and a professor at Harvard Medical School, where he was the dean from 2007 to 2016.
MedPage Today4h
Medicare Spends Billions on Oncology Drugs Offering Little Added Benefit
Ten drugs were classified as low or no added therapeutic benefit compared with alternatives, accounting for $6.7 billion in ...
Tackle these 17 health factors to lower your risk for dementia, stroke and depression, study says
Many cases of dementia, stroke and late-life depression could be prevented or delayed by managing these 17 risk factors.
What’s lost: Trump whacks tiny agency that works to make the nation’s health care safer
On April 1, the Trump administration slashed the Agency for Healthcare Research and Quality, or AHRQ, and fired roughly half ...
Trump administration axes more than $125M in LGBTQ health funding, upending research field
In recent weeks, academics who focus on improving the health of lesbian, gay, bisexual, transgender and queer Americans have ...
Is Magnesium a Magical Cure for Troubled Sleep?
Thanks to claims by influencers and celebrities, the supplement is flying off the shelves. Whether it actually helps beat ...
How A Small Number of Mutations Can Fuel Outbreaks of Western Equine Encephalitis Virus
New research shows how small shifts in the molecular makeup of a virus can profoundly alter its fate. These shifts could turn ...
The Harvard Crimson12h
Trump Admin’s $9 Billion Review of Harvard’s Grants Could Hit Boston’s Hospitals Hardest
The Trump administration’s sweeping federal review of nearly $9 billion in multi-year research funding tied to Harvard has ...
Meduza17h
U.S. denies parole to Harvard scientist from Russia, citing national security threat. She fears persecution for anti-war statements if deported.
The Trump administration has denied parole to Kseniia Petrova, a Harvard Medical School researcher from Russia who was ...
Trump’s next tariffs target could be foreign-made medicines
President Trump wants to bring pharmaceutical manufacturing back to the U.S. Experts warn tariffs could result in shortages ...
Healio10h
‘Pivotal moment’: Uplizna becomes first FDA-approved treatment for IgG4-related disease
The FDA on Thursday gave the green light to Uplizna in IgG4-related disease, making it the first and only approved treatment ...